GENTILINI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.972
EU - Europa 9.374
AS - Asia 6.745
SA - Sud America 720
AF - Africa 204
OC - Oceania 167
Continente sconosciuto - Info sul continente non disponibili 4
Totale 35.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.812
RU - Federazione Russa 3.831
SG - Singapore 1.896
CN - Cina 1.338
HK - Hong Kong 1.212
SE - Svezia 1.007
IE - Irlanda 972
PL - Polonia 825
KR - Corea 725
VN - Vietnam 684
BR - Brasile 602
UA - Ucraina 582
IT - Italia 570
DE - Germania 466
FI - Finlandia 347
FR - Francia 306
GB - Regno Unito 250
IN - India 232
JP - Giappone 193
AU - Australia 162
TR - Turchia 159
CA - Canada 88
CH - Svizzera 70
CI - Costa d'Avorio 64
JO - Giordania 57
BD - Bangladesh 54
AR - Argentina 43
IQ - Iraq 40
NL - Olanda 40
NG - Nigeria 38
MX - Messico 34
BE - Belgio 25
ZA - Sudafrica 25
ES - Italia 22
ID - Indonesia 22
MA - Marocco 20
UZ - Uzbekistan 20
EC - Ecuador 19
PK - Pakistan 17
CO - Colombia 15
SC - Seychelles 15
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
KE - Kenya 11
JM - Giamaica 10
PH - Filippine 10
EG - Egitto 9
LT - Lituania 9
MY - Malesia 9
AZ - Azerbaigian 8
DZ - Algeria 8
SA - Arabia Saudita 8
AT - Austria 7
BG - Bulgaria 7
KG - Kirghizistan 7
PE - Perù 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
HN - Honduras 6
LV - Lettonia 6
PY - Paraguay 6
CL - Cile 5
OM - Oman 5
PT - Portogallo 5
TN - Tunisia 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
EU - Europa 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BY - Bielorussia 3
CY - Cipro 3
GR - Grecia 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
LB - Libano 3
NP - Nepal 3
PA - Panama 3
ET - Etiopia 2
GT - Guatemala 2
GY - Guiana 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MU - Mauritius 2
NI - Nicaragua 2
RO - Romania 2
SN - Senegal 2
TW - Taiwan 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
Totale 35.171
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.756
Singapore 1.249
Fairfield 1.223
Ashburn 1.137
Chandler 1.075
Hong Kong 974
Dublin 971
Jacksonville 914
San Jose 873
Warsaw 815
Seoul 720
Woodbridge 594
Cambridge 563
Seattle 548
Wilmington 452
Houston 445
Beijing 387
Los Angeles 351
The Dalles 332
Buffalo 313
Princeton 262
Ann Arbor 250
Ho Chi Minh City 214
Lauterbourg 209
Boston 200
Boardman 198
Tokyo 192
Dallas 189
Melbourne 163
Hanoi 161
Hefei 160
Mumbai 139
Medford 122
Lawrence 118
Altamura 114
Izmir 107
Moscow 92
Munich 78
New York 76
San Diego 73
Bern 68
Norwalk 67
Abidjan 64
Shanghai 60
Kent 50
Paris 50
Dearborn 47
Helsinki 45
Milan 45
São Paulo 41
Redondo Beach 40
Abuja 37
Turku 37
Orem 34
Da Nang 33
Florence 33
London 33
Toronto 33
Andover 32
Hillsboro 31
Falls Church 30
Auburn Hills 27
Chicago 27
Guangzhou 27
Bremen 25
Brussels 25
Frankfurt am Main 25
Frankfurt Am Main 24
Haiphong 24
West Jordan 24
Chennai 23
Brooklyn 21
Manchester 19
Montreal 19
Tashkent 19
Verona 19
Baghdad 18
Rome 18
Washington 18
Salerno 16
Stockholm 16
Atlanta 15
Dhaka 15
Yubileyny 15
Belo Horizonte 14
San Francisco 14
Denver 13
Jakarta 13
Rio de Janeiro 13
Johannesburg 12
Nha Trang 12
Tianjin 12
Amman 11
Amsterdam 11
Biên Hòa 11
Chandigarh 11
Curitiba 10
Dong Ket 10
Hải Dương 10
Philadelphia 10
Totale 22.385
Salva come PNG Salva come JPEG
Nome #
Serum hepatitis delta virus RNA in patients with delta hepatitis and in liver graft recipients 1.197
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 338
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 309
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 305
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 298
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx 279
Fat-storing cells as liver-specific pericytes: spatial dynamic of agonist-stimulated intracellular calcium transients. 266
The kinin system and other vasoactive substances in chronic liver disease. 236
[Renal function in chronic hepatopathies] 230
[Some aspects of the physiopathology of renal insufficiency in the course of chronic liver diseases] 230
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 219
Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning 219
SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY PERCUTANEOUS ETHANOL INJECTION: A 10-YEAR EXPERIENCE. 218
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 211
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 210
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells 203
Bile acid inhibition of p-glycoprotein mediated transport in multidrug resistant cells and rat liver canalicular membrane vesicles 199
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 193
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 193
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 189
Hepatocellular carcinoma in mixed cryoglobulinemia patients 186
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 185
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 184
Analysis of HCV persistence in patients with sustained virological response 184
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 183
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 182
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 181
Functional insufficiency in chronic liver disease patients. The hepatorenal syndrome 181
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 180
Infection of peripheral mononuclear blood cells by hepatitis C virus 179
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 179
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 178
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 177
Ascites and hepatorenal syndrome 177
Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists 177
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 176
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 174
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 174
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 174
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 173
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 173
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 172
Expression of platelet-derived growth factor in a model of acute liver injury. 170
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 170
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 168
Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients 167
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 167
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 166
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 165
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 164
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 164
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 164
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 163
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 163
T(14;18) translocation in chronic hepatitis C virus infection 162
Loop diuretic therapy in liver cirrhosis with ascites 162
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 162
Amplification of HDV RNA sequences by polymerase chain reaction (PCR). 161
Fibrogenesi epatica: valutazione dell'espressione genica di citochine fibrogeniche e dei tipi più rappresentanti di collagene. 161
Patterns and mechanisms of hepatitis B/hepatitis D reinfection after liver transplantation 158
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 158
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 157
Defective signal transduction in platelets from cirrhotic patients is associated with increased cyclic AMP and cyclic GMP content. 156
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 156
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 156
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. 155
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 155
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 155
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 154
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis 151
Pathogenesis and treatment of ascites in hepatic cirrhosis. 151
Crioglobulinemia e linfoma in corso di infezione da HCV 151
Multiple biological effects of endothelin-1 in fat-storing cells isolated from human liver. 150
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 150
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. 150
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 149
Torasemide in the treatment of patients with cirrhosis and ascites. 149
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 149
Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and non alcoholic liver disease. 147
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 147
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 146
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 146
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 144
Chemotherapy of primary and secondary liver cancer: is it useful? 143
Respiratory mechanics in patients with tense cirrhotic ascites. 143
Impaired superoxide anion, platelet-activating factor, and leukotriene B4synthesis by neutrophils in cirrhosis. 143
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA 142
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 142
Endothelin-1 is overexpressed in cirrhotic liver and exerts multiple effects on activated human hepatic stellate cells. 142
Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis. 142
[Determination of prostaglandin E2 and F2 alpha in the urine of cirrhotic patients: comparison of 3 different chromatographic methods] 142
The cellular and molecular basis of liver fibrogenesis. 141
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 141
Organization of the lymphoid tissue in livers with chronic active hepatitis. 141
Drugs and the Liver. Pharmacokinetc factors and drug-induced liver disease 141
Uveitis in autoimmune hepatitis: a case report. 139
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 139
Hepatitis C virus infection, malignancy and liver transplantation 138
Le epatiti croniche 138
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 138
Totale 18.505
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 0 0 0 0 0 133 178
2021/20221.560 24 192 46 71 42 51 49 80 66 42 374 523
2022/20234.160 425 423 198 318 430 836 569 248 467 28 119 99
2023/20241.241 64 179 277 76 77 144 35 258 22 31 40 38
2024/202510.312 304 1.093 730 1.569 3.508 1.078 94 613 538 210 316 259
2025/20268.882 1.313 1.432 716 926 1.063 324 1.151 412 871 515 159 0
Totale 35.230